Acinetobacter baumannii has emerged as a medically important pathogen because of the
increasing number of infections produced by this organism over the preceding three …

Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose
resistance patterns result in significant challenges for the clinician. Despite the prevalence …

The emergence of multidrug-resistant (MDR) Gram-negative bacilli creates a big problem for
the treatment of nosocomial infections. As the pharmaceutical pipeline wanes, the only …

Acinetobacter baumannii ventriculitis/meningitis due to the emergence of multidrug-resistant
(MDR) and extensively drug-resistant (XDR) strains has become a clinical entity of …

Acinetobacter baumannii has been a major cause of nosocomial infections for decades. The
absence of an available vaccine coupled with emerging multidrug resistance has prevented …

Introduction: Although the clinical importance of Acinetobacter pittii and Acinetobacter
nosocomialis has increased in the nosocomial setting in the last decade, infections caused …

Multidrug-resistant (MDR) superbugs can breach the blood–brain barrier (BBB), leading to a
continuous barrage of pro-inflammatory modulators and induction of severe infection-related …

Background and purpose Reports on the safety and efficacy of intraventricularly
administered (IVT) colistin for the treatment of Acinetobacter baumannii ventriculomeningitis …

Objective: To assess the prevalence and outcome of external cerebral ventricular drainage-
associated ventriculitis in neurocritical patients before and after the implementation of a …

Multidrug-resistant organisms are an established and growing worldwide public health
problem and few therapeutic options remain available. The traditional antimicrobials …